Centre for Addiction and Mental Health clinical trial pipeline
Data updated daily from ClinicalTrials.gov, last refresh 2026-11-19
What changed in the last 30 days
6 trials changed in the last 30 days: 0 stopped, 1 with a notable change, 5 with minor changes only.
- Minor: PAS-MCI · Enhancing Frontal Lobes Plasticity in Mild Cognitive Impairment Primary completion date changed from estimate of Oct 1, 2026 to Aug 14, 2026
- Minor: Cannabidiol as a Novel Anticraving Medication for Alcohol Use Disorder Study completion pushed from Sep 30, 2026 to Jan 31, 2027
- Notable: Psilocybin-assisted Therapy for Comorbid Major Depressive Disorder and Alcohol Use Disorder Recruitment opened
- Minor: PAT-DA · Psilocybin for Treatment-Resistant Depression in Autism Final enrollment: 18 participants (planned 20)
- Minor: Integrated Collaborative Care Teams for Youth With Mental Health and/or Addiction Challenges (YouthCan IMPACT) Trial completed
- Minor: Narrative Enhancement and Cognitive Therapy for Self-Stigma in Youth Trial completed
- Stopped: terminated, suspended or withdrawn
- Notable: the plan changed
- Minor: routine updates
Active trials by phase
| Phase 1 | 2 | |
| Phase 2 | 5 | |
| Phase 4 | 8 |
Not charted: 55 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).
Disease areas by active trials, top 10 of 12
Depression (20) · Schizophrenia (12) · Dementia (6) · Alzheimer's Disease (5) · Bipolar Disorder (5) · Anxiety (3) · Diabetes (2) · ADHD (1) · Obesity (1) · PTSD (1)
Get alerts when Centre for Addiction and Mental Health's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.